[Event Report] The Our View, Our Voices Workshop for Building Advocacy Skills and Developing Confidence for Spokespeople Among People living with NCDs (December 22, 2019)
date : 2/7/2020
![[Event Report] The Our View, Our Voices Workshop for Building Advocacy Skills and Developing Confidence for Spokespeople Among People living with NCDs (December 22, 2019)](https://hgpi.org/en/wp-content/uploads/sites/2/ovov-top.jpg)
PPeCC and NCD Alliance Japan (with administrative support from HGPI) co-hosted the Japan Our Views, Our Voices workshop on December 12th, 2019 to strengthen the advocacy skills of people living with non-communicable diseases (NCDs) and other parties most affected by NCDs.
Our Views, Our Voices is a new style of workshop for strengthening the advocacy skills of people living with NCDs such as cancer, diabetes, cardiovascular diseases, chronic respiratory diseases, and mental illnesses using world-standard methods developed by NCD Alliance . Ms. Haruka Ikezaki of PPeCC and Representative Director of Heart Valve Voice Mr. Hitoshi Fukuhara joined the event as peer trainers and facilitators. They had previously participated in NCD Alliance’s June 2019 Train-the-Trainer Workshop in Geneva.
The event had twelve participants from organizations and groups for NCDs that are involved with various diseases. In addition to learning basic information about healthcare and NCDs, participants learned strategies for representing people with NCDs effectively by summarizing and sharing their personal experiences. Practical exercises on using elevator pitches to quickly win over listeners were also conducted.
In the future, NCD Alliance Japan will continuously work to strengthen the advocacy abilities of people living with NCDs and other parties most affected by NCDs.
* NCD Alliance: A collaborative platform bringing together over 2000 civil society organizations and academic institutions in more than 170 countries
Top Research & Recommendations Posts
- [Policy Recommendation] Preparing for “Disaster-Level Heat” in the 2025 Basic Policy on Economic and Fiscal Management and Reform (June 9, 2025)
- [Policy Recommendation] Integrating “Planetary Health” as a Growth Strategy — Proposal for the Grand Design and Action Plan for a New Form of Capitalism (2025 Revised Edition) (June 9, 2025)
- [Event Report] Round Table Discussion “Understanding Menopausal Women’s Health as a Social Issue” (November 19, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] HGPI Joint Input to the Zero Draft Political Declaration on NCDs and Mental Health (May 23, 2025)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
Featured Posts
-
2025-07-04
[Registration Open] (Webinar) The 136th HGPI Seminar “Where We Are Now and Where We Are Going Regarding PPI in Mental Health Research: Learning from the TOGETHER Project in the Form of Co-Creation” (July 28, 2025)
-
2025-07-04
[Event Report] The HGPI Cardiovascular Disease (CVD) Control Promotion Project Online Global Symposium “Exploring the Future of CVD Control Through Policy Case Studies in the Asia-Pacific Region” (March 13, 2025)
-
2025-07-04
[HGPI Policy Column] (No. 62) From the Dementia Project “The Current State of Dementia Policy in the International Community in 2025”
-
2025-07-04
[Recommendations] HGPI Expert Policy Advocacy Platform “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 7, 2025)